In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib

British Journal of Haematology

Volumn 112, Issue 3, 2001, Pages 621-631

  Meiklejohn, D J ^a   Vickers, M A ^a   Morrison, E R ^a   Dijkhuisen, R ^b   Moore, I ^c   Urbaniak, S J ^c   Greaves, M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NHS GRAMPIAN   (United Kingdom)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Glycoprotein polymorphisms; Platelet activation; Thrombotic stroke

Indexed keywords

FIBRINOGEN; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; PADGEM PROTEIN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; STROKE; THROMBOCYTE ACTIVATION; THROMBOSIS;

CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHI-SQUARE DISTRIBUTION; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 0035106025     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02620.x     Document Type: Article

References (51)

1. Role of platelet glycoprotein PL (A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty
2. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3. Integrin polymorphisms as risk factors for thrombosis
4. Association of the platelet Pl (A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease
5. Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke
6. HPA genotyping by PCR sequence-specific priming (PCR-SSP): A streamlined method for rapid routine investigations
7. PlA2 polymorphism and efficacy of aspirin
8. A common polymorphism flanking the ATG initiator codon of GP1ba does not affect expression and is not a major risk factor for arterial thrombosis
9. Platelet aggregation, stroke, and transient ischemic attack in middle-aged and elderly patients
10. The role of platelets in ischemic stroke
11. A1/A2 and vascular risk: A meta-analysis
12. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease
13. Experimental cerebral ischemia produces platelet aggregates
14. Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism
15. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study
16. Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis
17. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients
18. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease
19. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease
20. The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde
21. Spontaneous platelet aggregation in cerebrovascular disease II. Further characterisation of the platelet defect
22. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa
23. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement
24. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls
25. Shear-induced platelet aggregation in normal subjects and stroke patients
26. Interdonor variability of platelet response to thrombin receptor activation: Influence of PlA2 polymorphism
27. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A case-controlled study
28. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction
29. Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): No association with platelet fibrinogen binding
30. Flow cytometry: A clinical test of platelet function
31. Platelet GP IIIa Pl (A) polymorphisms display different sensitivities to agonists
32. Glycoprotein IIIa Pl (A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly
33. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation
34. The human platelet alloantigens. PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing
35. Polymorphisms of human platelet membrane glycoproteins: Structure and clinical significance
36. Platelet glycoprotein IIIa polymorphism and coronary thrombosis
37. Platelet glycoprotein IIIa gene polymorphism and myocardial infarction
38. Assessment of genetic markers for coronary thrombosis: Promise and precaution
39. PlA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis
40. Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm
41. Glycoprotein IIIa polymorphism and risk of myocardial infarction
42. Enhanced in vivo platelet activation in subtypes of ischemic stroke
43. Association between platelet glycoprotein Iba genotype and ischemic cerebrovascular disease
44. Platelet hyperreactivity and prognosis in survivors of myocardial infarction
45. Platelet activation and lipid peroxidation in patients with acute ischemic stroke
46. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage
47. Platelet glycoprotein receptor IIIa polymorphism PlA2 and ischemic stroke risk: The Stroke Prevention in Young Women Study
48. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
49. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: A micromethod for the detection of platelet activation
50. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
51. Polymorphism of platelet membrane glycoprotein IIIa: Human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease